JP2024518413A5 - - Google Patents
Info
- Publication number
- JP2024518413A5 JP2024518413A5 JP2023568340A JP2023568340A JP2024518413A5 JP 2024518413 A5 JP2024518413 A5 JP 2024518413A5 JP 2023568340 A JP2023568340 A JP 2023568340A JP 2023568340 A JP2023568340 A JP 2023568340A JP 2024518413 A5 JP2024518413 A5 JP 2024518413A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163185315P | 2021-05-06 | 2021-05-06 | |
| US63/185,315 | 2021-05-06 | ||
| US202263315483P | 2022-03-01 | 2022-03-01 | |
| US63/315,483 | 2022-03-01 | ||
| PCT/US2022/028208 WO2022236147A1 (en) | 2021-05-06 | 2022-05-06 | Modified nucleases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024518413A JP2024518413A (ja) | 2024-05-01 |
| JPWO2022236147A5 JPWO2022236147A5 (https=) | 2025-05-13 |
| JP2024518413A5 true JP2024518413A5 (https=) | 2025-05-13 |
Family
ID=81975392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023568340A Pending JP2024518413A (ja) | 2021-05-06 | 2022-05-06 | 修飾ヌクレアーゼ |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US20260009009A1 (https=) |
| JP (1) | JP2024518413A (https=) |
| CA (1) | CA3218053A1 (https=) |
| WO (1) | WO2022236147A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2024007790A (es) | 2021-12-22 | 2024-09-06 | Camp4 Therapeutics Corp | Modulación de la transcripción génica utilizando oligonucleótidos antisentido dirigidos a arn reguladores. |
| IL324634A (en) | 2023-05-15 | 2026-01-01 | Nchroma Bio Inc | Compositions and methods for epigenetic regulation of hbv gene expression |
| WO2026046724A1 (en) * | 2024-08-30 | 2026-03-05 | Cellectis Sa | Tale protein scaffolds involving fusions of monopartite and bipartite nls |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9790490B2 (en) | 2015-06-18 | 2017-10-17 | The Broad Institute Inc. | CRISPR enzymes and systems |
| WO2017106569A1 (en) * | 2015-12-18 | 2017-06-22 | The Regents Of The University Of California | Modified site-directed modifying polypeptides and methods of use thereof |
| US9896696B2 (en) | 2016-02-15 | 2018-02-20 | Benson Hill Biosystems, Inc. | Compositions and methods for modifying genomes |
| JP7136816B2 (ja) * | 2017-06-23 | 2022-09-13 | インスクリプタ， インコーポレイテッド | 核酸誘導型ヌクレアーゼ |
| US9982279B1 (en) | 2017-06-23 | 2018-05-29 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| US10011849B1 (en) * | 2017-06-23 | 2018-07-03 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| US11649442B2 (en) * | 2017-09-08 | 2023-05-16 | The Regents Of The University Of California | RNA-guided endonuclease fusion polypeptides and methods of use thereof |
| WO2019118516A1 (en) * | 2017-12-11 | 2019-06-20 | Editas Medicine, Inc. | Cpf1-related methods and compositions for gene editing |
| EP3821008A1 (en) * | 2018-07-12 | 2021-05-19 | Keygene N.V. | Type v crispr/nuclease-system for genome editing in plant cells |
| AU2019368215B2 (en) * | 2018-10-22 | 2023-05-18 | Inscripta, Inc. | Engineered enzymes |
| WO2020092057A1 (en) * | 2018-10-30 | 2020-05-07 | Yale University | Compositions and methods for rapid and modular generation of chimeric antigen receptor t cells |
| CN113039278A (zh) * | 2018-10-31 | 2021-06-25 | 诺维信公司 | 通过指导的内切核酸酶和单链寡核苷酸进行基因组编辑 |
| EP3887538A1 (en) * | 2018-11-28 | 2021-10-06 | Keygene N.V. | Targeted enrichment by endonuclease protection |
| CA3153700A1 (en) * | 2019-09-09 | 2021-03-18 | Scribe Therapeutics Inc. | Compositions and methods for use in immunotherapy |
| AU2020358863A1 (en) | 2019-10-03 | 2022-05-12 | Celyntra Therapeutics Sa | CRISPR systems with engineered dual guide nucleic acids |
| US20230348869A1 (en) * | 2019-10-14 | 2023-11-02 | KWS SAAT SE & Co. KGaA | Mad7 nuclease in plants and expanding its pam recognition capability |
| CA3166430A1 (en) | 2020-02-05 | 2021-08-12 | Ryan T. Gill | Compositions and methods for targeting, editing or modifying human genes |
-
2022
- 2022-05-06 CA CA3218053A patent/CA3218053A1/en active Pending
- 2022-05-06 WO PCT/US2022/028208 patent/WO2022236147A1/en not_active Ceased
- 2022-05-06 US US18/289,723 patent/US20260009009A1/en active Pending
- 2022-05-06 JP JP2023568340A patent/JP2024518413A/ja active Pending
-
2023
- 2023-04-28 US US18/141,363 patent/US20230340437A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2026000321A1 (es) | Conmutación de tci dual basada en dci para ue con capacidad para múltiples rx | |
| CL2025003138A1 (es) | Sistema de filtración por membrana | |
| CN307044631S (https=) | ||
| BY13135U (https=) | ||
| CN307049998S (https=) | ||
| CN307049445S (https=) | ||
| BY13137U (https=) | ||
| CN307048592S (https=) | ||
| CN307048486S (https=) | ||
| CN307047726S (https=) | ||
| CN307047482S (https=) | ||
| CN307047004S (https=) | ||
| CN307046274S (https=) | ||
| CN307046121S (https=) | ||
| CN307045983S (https=) | ||
| CN307045608S (https=) | ||
| CN307045517S (https=) | ||
| CN307044908S (https=) | ||
| CN307044806S (https=) | ||
| CN307044757S (https=) | ||
| BY23963C1 (https=) | ||
| BY13176U (https=) | ||
| BY13175U (https=) | ||
| BY13174U (https=) | ||
| BY13172U (https=) |